Both in Pharmaceuticals
Skye Bioscience vs Scienture Holdings
Over the past year SKYE returned −86.0% and SCNX returned −74.9%; their daily moves had a correlation of 0.00.
SKYE −86.0% SCNX −74.9%Growth of $1, one year, split-adjusted
| Metric | SKYE | SCNX |
|---|---|---|
| Price | $1.55 | $3.36 |
| Market cap | $6.9M | $5.5M |
| Today | −2.52% | −0.59% |
| 1 month | −1.3% | −57.1% |
| 6 months | −75.4% | −66.0% |
| Year to date | −74.2% | −73.6% |
| 1 year | −87.3% | −81.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 97.7% |
| Net margin | — | −821.3% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.9M | -$1.4M |
| Dividend yield | — | — |
| Volatility (60d) | 616.6% | 932.8% |
| Short % of float | 0.7% | 3.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).